Compare NTCT & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTCT | PRGO |
|---|---|---|
| Founded | 1984 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1999 | 1991 |
| Metric | NTCT | PRGO |
|---|---|---|
| Price | $29.59 | $14.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $31.00 | $20.33 |
| AVG Volume (30 Days) | 486.9K | ★ 2.2M |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 7.98% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | $861,434,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $5.90 | N/A |
| Revenue Next Year | $2.62 | N/A |
| P/E Ratio | $22.49 | ★ N/A |
| Revenue Growth | ★ 4.91 | N/A |
| 52 Week Low | $18.12 | $12.17 |
| 52 Week High | $30.67 | $30.93 |
| Indicator | NTCT | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 64.53 | 51.72 |
| Support Level | $27.80 | $14.20 |
| Resistance Level | $28.72 | $14.74 |
| Average True Range (ATR) | 0.99 | 0.48 |
| MACD | 0.13 | 0.00 |
| Stochastic Oscillator | 98.91 | 77.42 |
NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.